Which biologics work for pustular psoriasis?

Systematic review pulls together the sparse evidence on the topic

Infliximab is the first-line agent of choice for pustular psoriasis, dermatologists suggest, but ustekinumab is a good alternative. 

pustular psoriasis

Researchers conducted a systematic review analysing data from about 40 articles, published between 2012 and 2018, on biologic therapies used to manage the rare but potentially life-threatening disease.

The dermatologists, from the University of Puerto Rico’s Medical Science Campus, said there was limited evidence on pustular psoriasis treatment strategies.

“Factors including its relatively